Loading...
ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma
Harrison, Palmer D Ross, PJ Silcocks, P Greenhalf, W Faluyi, O Ma, YT Wadsley, J Rawcliffe, C Neoptolemos, J
Harrison, Palmer D
Ross, PJ
Silcocks, P
Greenhalf, W
Faluyi, O
Ma, YT
Wadsley, J
Rawcliffe, C
Neoptolemos, J
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 104.81 KB
Keywords
Type
Meetings and Proceedings
Citation
Harrison Palmer D, Ross PJ, Silcocks P, Greenhalf W, Faluyi O, Ma YT, et al. 788TiP ACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma. Annals of Oncology. 2018;29(suppl_8).